Stemnovate- Redefining drug discovery

Stemnovate- Redefining drug discovery Stemnovate is a pioneering R&D company in Cambridge, UK on a mission to accelerate drug discovery.

Accelerate breakthroughs in early-onset Parkinson’s disease.Our advanced cell-modelling platform integrates genetic, phy...
02/09/2026

Accelerate breakthroughs in early-onset Parkinson’s disease.

Our advanced cell-modelling platform integrates genetic, physiological, and epigenetic insights to deliver the most comprehensive understanding of disease mechanisms—keeping patients at the heart of discovery.

Partner with us to transform Parkinson’s research and accelerate therapeutic innovation. Stemnovate Limited

Explore the platform:
https://hubs.la/Q04wdpqq0

Connect with us today to collaborate.

Accelerate breakthroughs in early-onset Parkinson’s disease.Our advanced cell-modelling platform integrates genetic, phy...
02/09/2026

Accelerate breakthroughs in early-onset Parkinson’s disease.

Our advanced cell-modelling platform integrates genetic, physiological, and epigenetic insights to deliver the most comprehensive understanding of disease mechanisms—keeping patients at the heart of discovery.

Partner with us to transform Parkinson’s research and accelerate therapeutic innovation. Stemnovate Limited

Explore the platform:
https://hubs.la/Q04wdbS_0

Connect with us today to collaborate.

Beany, our mascot, embodies our unwavering dedication to compassionate and ethical research. Stemnovate is at the forefr...
02/09/2026

Beany, our mascot, embodies our unwavering dedication to compassionate and ethical research. Stemnovate is at the forefront of providing innovative alternatives to animal testing, sourcing animal cells exclusively through ethical tissue donation in partnership with leading veterinary clinics.Our comprehensive biobank includes a wide range of multi-species cells, each meticulously screened for notifiable diseases and microbial contamination using advanced metagenomics analysis. We elevate research standards with state-of-the-art sequencing for precise species characterisation and advanced cell modelling, supported by custom-designed cell culture media.

Trusted by top animal health companies and premier research institutions, Stemnovate empowers you to conduct research more ethically and impactfully. Choose our products to advance science, support animal welfare, and explore pioneering alternatives.

We have offers, student discounts and multi-buy deals, so excel in 2026 with Stemnovate.

https://hubs.la/Q04wd6X10

Stemnovate Limited

Ready to elevate your research? Get a quote, subscribe, or buy now—visit our website to discover more!Buying these produ...
02/09/2026

Ready to elevate your research? Get a quote, subscribe, or buy now—visit our website to discover more!

Buying these products supports our research on rare diseases in children and reduces animal testing. Join us in promoting business sustainability and supporting good causes in science and medicine.

https://hubs.la/Q04wdj9y0

Stemnovate Limited

Thank you for the warm wishes on Stemnovate Limited 10th anniversary. This milestone reflects the team's unwavering pers...
02/09/2026

Thank you for the warm wishes on Stemnovate Limited 10th anniversary. This milestone reflects the team's unwavering perseverance during challenging times.

Our breakthroughs in rare childhood diseases and advancements in animal alternatives showcase our commitment to both human and animal welfare. The One Medicine data platform exemplifies our dedication to innovation and transforming lives. These achievements reinforce our promise to continue pushing boundaries.

We are embracing new R&D challenges in children's diseases and initiating work on Duchenne Muscular Dystrophy. Each project and conversation represents an opportunity to deliver hope and solutions for patients where time is critical. Together, we can make an even greater impact for those who cannot wait.

For inquiries, please reach out at [email protected] and participate through an easy online process on our website. https://hubs.la/Q04wdMwk0

The biggest challenge in researching rare diseases lies not only in diagnosis and treatment but also in developing appro...
02/09/2026

The biggest challenge in researching rare diseases lies not only in diagnosis and treatment but also in developing appropriate models to test potential drug molecules and interventions. Factors such as the young age of affected children, the rarity of the condition, and limited funding all contribute to these challenges. However, we are actively working to overcome these barriers.

We have brought children from various parts of the world to our platform and created neuronal models to accelerate the pace of research.

Contact us to learn more about our platform for mitochondrial rare diseases.

https://hubs.la/Q04wd8Gz0
Stemnovate Limited

We are excited to announce that the Stemnovate Limited Ambassador Programme is going live this September! This incredibl...
02/09/2026

We are excited to announce that the Stemnovate Limited Ambassador Programme is going live this September! This incredible initiative brings together the next generation of scientists—including undergraduates, postgraduates, PhDs, and early-career researchers—from leading institutions such as the University of Cambridge Imperial College London King's College London , the University of Bristol, the University of Sheffield, and many more. Our goal is to create a collaborative space where scientific communication is accessible to everyone. Here, complex, cutting-edge scientific advancements will be explained in clear, non-technical language, ensuring no one misses out on discoveries that can help us all live better lives. We’re thrilled to share that more than 60 passionate applicants have joined our first cohort, and the community continues to grow! The inaugural group is ready to embark on this journey starting in September. Stay tuned for engaging webinars, insightful blogs, and a vibrant community dedicated to making science accessible to all. In addition, we’re launching a brand new app to connect our Ambassador community even more closely. Watch this space for updates and get ready to be part of a movement that’s redefining science communication!

https://hubs.la/Q04wdNf80

FDA approval of exon-skipping therapies for Duchenne muscular dystrophy (DMD) marks tremendous progress—yet it’s just th...
02/09/2026

FDA approval of exon-skipping therapies for Duchenne muscular dystrophy (DMD) marks tremendous progress—yet it’s just the beginning. While treatments like Exondys 51, Vyondys 53, Viltepso, and Amondys 45 are milestones for those with specific gene deletions, DMD mutations span all 79 exons. Many children still have no targeted therapy.

At Stemnovate Limited, we believe no child should be left behind. Our work goes beyond pinpointing genetic mutations—we are pioneering the creation of unique models for every child, accelerating the development of therapies tailored to their exact needs, wherever they are in the world.

Precision medicine shouldn’t be a privilege for a few; it should be a promise for all. Let’s build a future where every child with DMD has hope. Discover more about our mission and join us in making a difference: https://hubs.la/Q04wdjlg0

As a volunteer, you will receive a free genomic analysis to understand your condition better. Your participation will be...
02/09/2026

As a volunteer, you will receive a free genomic analysis to understand your condition better. Your participation will benefit you and contribute to the development of new treatments.
https://hubs.la/Q04wdnhc0

Stemnovate Limited

Accelerate breakthroughs in early-onset Parkinson’s disease.Our advanced cell-modelling platform integrates genetic, phy...
01/09/2026

Accelerate breakthroughs in early-onset Parkinson’s disease.

Our advanced cell-modelling platform integrates genetic, physiological, and epigenetic insights to deliver the most comprehensive understanding of disease mechanisms—keeping patients at the heart of discovery.

Partner with us to transform Parkinson’s research and accelerate therapeutic innovation. Stemnovate Limited

Explore the platform:
https://hubs.la/Q04w269s0

Connect with us today to collaborate.

Address

Babraham Research Campus
Babraham
CB223AT

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 9am - 5pm
Sunday 9am - 5pm

Telephone

+441223830192

Website

Alerts

Be the first to know and let us send you an email when Stemnovate- Redefining drug discovery posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Stemnovate- Redefining drug discovery:

Shortcuts

Share

Category